Delivery Order SPE2DE21D7020-SPE2D625F0RQY

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are specialized medical devices used in interventional cardiology and vascular procedures to prevent restenosis and improve patient outcomes. This delivery order aligns with Boston Scientific's established role as a critical supplier of advanced cardiovascular and interventional medical technologies to federal healthcare agencies.

This award is consistent with Boston Scientific's broader federal contracting portfolio, which includes significant indefinite delivery vehicles and blanket purchase agreements with the Defense Health Agency and Veterans Integrated Service Networks. The company maintains multiple active contracts ranging from specialized radiation treatment devices to cardiac intervention tools, positioning it as a key supplier of innovative medical equipment to federal healthcare systems. The relatively short performance timeline and modest contract value indicate this delivery order represents a discrete procurement under an existing larger vehicle or framework agreement.